Lunsumio (Mosunetuzumab)

**Product type:** Human Prescription Drug

**Active ingredient:** MOSUNETUZUMAB

**Strength:** 30 mg/30mL

**Dosage form:** Concentrate

**Route:** Intravenous

**Labeler:** Genentech, Inc.

**Marketing category:** BLA (BLA761263)